Background: Patch testing to a standard (baseline) series of allergens is the screening tool used to identify culprit allergens in patients with contact dermatitis. The allergens and concentrations used in a standard series are constantly evolving to be most relevant to the patients being patch tested.
Objective: The aim of this study was to analyze the 2011-2015 patch test results of the Mayo Clinic standard series.
Background: Patch testing is essential for identification of culprits causing allergic contact dermatitis.
Objective: We sought to identify trends and allergen changes in our standard series during 2006 to 2010, compared with our previous report (2001-2005).
Methods: We conducted a retrospective review of patch-test results.
Objective: To present and interpret results of patch testing with the Mayo Clinic standard series over 5 years.
Design: Retrospective study. A standardized patch testing technique was used.
In summary, a wide variety of skin care products contain preservatives. Patients who are allergic to one of these preservatives may have either localized or widespread dermatitis. Affected patients may find it difficult to avoid thimerosal without the help of the health care provider because the use of these allergens is so widespread.
View Article and Find Full Text PDFBackground: Patch testing is a diagnostic tool for the evaluation of patients with suspected allergic contact dermatitis. A standard series of allergens similar to that used by the North American Contact Dermatitis Group (NACDG) is used at Mayo Clinic.
Objective: Our aim was to report the results of patch testing with a standard series at Mayo Clinic from July 1, 1998, to Dec 31, 2000 and to compare our findings with those of the NACDG during the same period.